Textbook of cardiovascular medicine 6edition

... network analysis – to investigate the emergence, structure, and content of translational research in biomedicine by comparing research in cancer and cardiovascular medicine Journal inter-citation is ... sole clinical mix journal in the set, maintains links to both the clinical domain and the molecular biology domain This journal plays a key role linking diverse resear...

Ngày tải lên: 18/06/2014, 19:20

... network analysis – to investigate the emergence, structure, and content of translational research in biomedicine by comparing research in cancer and cardiovascular medicine Journal inter-citation is ... sole clinical mix journal in the set, maintains links to both the clinical domain and the molecular biology domain This journal plays a key role linking diverse resear...

Ngày tải lên: 20/06/2014, 03:20

... 11 80 FM 3 /15 /07 6:57 PM Page i Textbook of Interventional Cardiovascular Pharmacology 11 80 FM 3 /15 /07 6:57 PM Page ii 11 80 FM 3 /15 /07 6:57 PM Page iii Textbook of Interventional Cardiovascular ... P-selectin, PAC -1 P PI LTA- ADP and Collagen- Induced PFA -1 0 0 P2Y 11 P2Y12 ion ”Autocrine and Paracrine Effect” TP CD40L P-selectin Peptidomimetics Figure 1. 3 C...

Ngày tải lên: 11/08/2014, 11:22

... molecular basis of granule secretion, signalling and cell adhesion Thromb Haemost 20 01; 86 :21 4 22 1 1180 Chap 02 3/14/07 40 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 11 :22 AM Page ... in high-risk PCI EPIC (8) RESTORE (9) CAPTURE (10) EPILOG (11) IMPACT II ( 12) EPISTENT (13) ESPRIT (14) ISAR-REACT (15) ISAR-REACT (16) 20 22 2159 20 64 23 99 4010 27...

Ngày tải lên: 11/08/2014, 11:22

... ( 24% ) 17/76 (22.3%) 52/76 (68 .4% ) 2 /44 (4. 5%) 23 /44 (52%) 28 /44 ( 64% ) 5 /44 (11.3%) 12 /44 (27%) 10 /44 (23%) 29 /44 (66%) 4/ 32 (12.5%) 24/ 32 (75%) 19/32 (59%) 10/32 (31%) 6/32 (19%) 7/32 (22%) 24/ 32 ... azo compound-initiated, and mononuclear 1180 Chap16 3/ 14/ 07 11:28 AM Page 183 References 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 cell-mediated oxidati...

Ngày tải lên: 11/08/2014, 11:22

... Stromelysin MMP-3 Stromelysin Stromelysin Membrane-type (MT-MMPs) MT1-MMP MMP-10 MMP-11 MT2-MMP MT3-MMP MT4-MMP MT5-MMP MT6-MMP Nonclassified MMPs Matrilysins MMP-15 MMP- 16 MMP-17 MMP-24 MMP-25 Metalloelastase ... model Circ J 2005; 69 :101–1 06 Gordon M, Margolin K, Talpaz M Phase I safety and pharmacokinetic study of recombinant human anti-vascular 54 55 56 57 58 59 60 61 62 63...

Ngày tải lên: 11/08/2014, 11:22

... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 379 cells and induces differentiation Mol Cell Biol 1988; 8:963– 973 Villa AE, Guzman LA, Poptic EJ, et al Effects of antisense c-myb oligonucleotides ... duration and low levels of transgene expression limit this approach Phospholipid formulae such as 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-dodecanoyl/1,2-dioleoyl-sn- glyce...

Ngày tải lên: 11/08/2014, 11:22

... failure: analysis of the experience in the MERIT-HF study J Am Coll Cardiol 2001; 38: 932–9 38 The-Beta-Blocker-Evaluation -of- Survival-Trial-Investigators A Trial of the beta-blocker bucindolol ... 332 :80 85 CIBIS-II-Investigators-and-Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 1999; 353:9–13 Beta-Blocker-Evaluation -of- Survival-Tria...

Ngày tải lên: 11/08/2014, 11:22

... 87 .9 82.2 8 59/ 76.3 8 79/ 76.4 616/ 71.2 662/ 71.4 1, 491 1,208/ 93 .7 1,888 1, 497 / 93 .2 514 396 / 89. 0 1,033/ 852/ 89. 4 85.5 1,256/ 1,028/ 88.0 82.7 360/ 293 / 84.4 76.5 Figure A Long-term outcome of ... Haemost 199 9; 82:507 Afshar-Kharghan V, Khoshnevis-Als M, Lopez J A Kozac sequence polymorphism is a major determinant of the surface levels of a platelet adhesion receptor...

Ngày tải lên: 11/08/2014, 11:22

... II-60 hr, VII-4–6 hr, IX-24 hr, X-4 8-7 2 hr (1) Return to baseline/ duration of activity Half-lifea For warfarin: mean of 40 hrs (1); dose-dependent, 47 hr for mg dose (15) AC effect in days (10) ; ... 570–571 ACS, 121–122 AMI, 102 clinical trials, 102 characteristics, 97 clinical outcomes, 572 dose, 102 103 parenteral, 100 101 PCI, 101 102 alternative anticoagulants, 104 peri-pe...

Ngày tải lên: 11/08/2014, 11:22